Please review the upcoming Test Changes, share updates with colleagues and staff members as appropriate, and implement necessary workflow changes by the specified effective dates.
|
Effective Date
| Test ID
Test Name | Change Type & Files |
|---|
| January 19, 2026 | LAB8664
Alpha Defensin, Lateral Flow Assay, Synovial Fluid-MAYO
|
NEW TEST | | January 19, 2026 | LAB8640
Anti-cN-1A (NT5c1A) IBM-MAYO
| NEW TEST | | January 19, 2026 | LAB8639 Apolipoprotein B-ARUP | NEW TEST | | January 19, 2026 | LAB8649
Autoimmune Dysautonomia Evaluation, serum (DYS2)-MAYO |
NEW TEST
| | January 19, 2026 | LAB8646
Axonal Neuropathy, Autoimmune - Paraneoplastic Evaluation, serum (AIAES)-MAYO |
NEW TEST
| | January 28, 2026 | LAB8675
Ganglioside Antibodies Evaluation, Serum-MAYO |
NEW TEST
| | January 19, 2026 | LAB8634
Glucotetrasaccharides (Hex4), Random, Urine-MAYO |
NEW TEST
| | January 19, 2026 | LAB8642
Helicobacter pylori with Clarithromycin Resistance Prediction, Molecular Detection, PCR, Tissue-MAYO |
NEW TEST
| | February 11, 2026 | LAB74
Immunoglobulin E |
SPECIMEN REQUIREMENTS
| | January 28, 2026 | LAB8673
Leptospira Antibody, IgM by Dot Blot-ARUP |
NEW TEST
| | February 4, 2026 | LAB8786
Lyso-GL-3-LCOR |
NEW TEST
| | January 19, 2026 | LAB8633
Mast Cell Mediators, 24 Hours, Urine-MAYO |
NEW TEST
| | January 19, 2026 | LAB8578
Mast Cell Mediators, Random, Urine-MAYO |
NEW TEST
| | January 19, 2026 | LAB8652
Movement Disorder, Autoimmune-Paraneoplastic Evaluation, Serum (MDS2)-MAYO |
NEW TEST
| | January 28, 2026 | LAB8680
Myositis Specific Antibody Evaluation, Serum-MAYO |
NEW TEST
| | January 19, 2026 | LAB8643
NPM1 Mutation Detection by RT-PCR, Quantitative-ARUP |
NEW TEST
| | January 19, 2026 | LAB8660
Pediatric Autoimmune Encephalopathy-CNS Disorder Evaluation, Serum (PCDES)-MAYO |
NEW TEST
| | January 19, 2026 | LAB8661
Pediatric Autoimmune Encephalopathy-CNS Disorder Evaluation, Spinal Fluid (PCDEC)-MAYO |
NEW TEST
| | January 19, 2026 | LAB8674
Plasma Cytokines-CINN |
NEW TEST
| | February 4, 2026 | LAB8788
Preeclampsia Risk Assessment (sFlt-1-PlGF Ratio)-ARUP |
NEW TEST
| | February 4, 2026 | LAB8784
Risankizumab Qt with Antibodies-MAYO |
NEW TEST
| | February 4, 2026 | LAB8785
Soluble C5b-9 Complement-VRCR
|
NEW TEST
| | January 19, 2026 | LAB8641
T-Cell Subsets, Naive, Memory, and Activated, Blood-MAYO |
NEW TEST
| | February 4, 2026 | LAB8787
Vasoactive Intestinal Polypeptide (VIP)-ARUP |
NEW TEST
| | February 4, 2026 | LAB8789
VMA and HVA, Rndm UR-ARUP |
NEW TEST
| | January 19, 2026 | LAB8638
Weak RhD Analysis-Versiti
|
NEW TEST
| | January 28, 2026 | LAB8672
Zika Virus by PCR, Blood-ARUP |
NEW TEST
| | January 28, 2026 | LAB8671
Zika Virus IgM Antibody Capture (MAC), by ELISA-ARUP |
NEW TEST
| | January 19, 2026 | LAB8637
Zinc Transporter 8 Antibody-MAYO |
NEW TEST
|
|
|
|
© 2025 VUMC. All Rights Reserved.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
445 Great Circle Rd | Nashville, TN 37228 US
|
|
|
This email was sent to tom.peters@vumc.org.
To continue receiving our emails, add us to your address book.
|
|
|
|